SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-18-323751
Filing Date
2018-11-09
Accepted
2018-11-09 16:02:02
Documents
5
Group Members
ACCESS INDUSTRIES HOLDINGS LLCACCESS INDUSTRIES MANAGEMENT, LLCACCESS INDUSTRIES, LLCBIO MEDICAL INVESTMENT (1997) LTD.CLAL BIOTECHNOLOGY INDUSTRIES LTD.LEN BLAVATNIK

Document Format Files

Seq Description Document Type Size
1 SC 13D d604295dsc13d.htm SC 13D 165186
2 EX-99.4 d604295dex994.htm EX-99.4 66858
3 EX-99.5 d604295dex995.htm EX-99.5 11819
4 EX-99.6 d604295dex996.htm EX-99.6 8332
5 GRAPHIC g604295page028.jpg GRAPHIC 7161
  Complete submission text file 0001193125-18-323751.txt   263956
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Subject) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90706 | Film No.: 181173046
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 40 WEST 57TH STREET 28TH FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH STREET 28TH FLOOR NEW YORK NY 10019 212-247-6400
AI Gamida Holdings LLC (Filed by) CIK: 0001757576 (see all company filings)

IRS No.: 825483591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D